These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 6201468

  • 1. Recognition of autologous lymphoblastoid cells by cloned human T cells: inhibition of cytotoxicity by anti-HLA antibody but not by antibody to Epstein-Barr virus induced cell surface antigen.
    Hank JA, Sondel PM.
    Hum Immunol; 1984 Apr; 9(4):211-9. PubMed ID: 6201468
    [Abstract] [Full Text] [Related]

  • 2. CD4+ proliferative T-cell clones reactive to autologous Epstein-Barr virus-transformed B cells (EBV-LCL) can be restricted by HLA class I molecules.
    Chen BP, DeMars R, Hank JA, Sondel PM.
    Cell Immunol; 1988 Sep; 115(2):363-72. PubMed ID: 2842068
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
    Tanaka Y, Sugamura K, Hinuma Y.
    J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
    [Abstract] [Full Text] [Related]

  • 4. Monoclonal antibodies to Epstein-Barr virus-induced, transformation-associated cell surface antigens: binding patterns and effect upon virus-specific T-cell cytotoxicity.
    Rowe M, Hildreth JE, Rickinson AB, Epstein MA.
    Int J Cancer; 1982 Apr 15; 29(4):373-81. PubMed ID: 6282762
    [Abstract] [Full Text] [Related]

  • 5. Establishment of human cytotoxic T-cell lines specific for Epstein-Barr virus-transformed autologous cells.
    Sugamura K, Tanaka Y, Hinuma Y.
    Int J Cancer; 1981 Aug 15; 28(2):137-42. PubMed ID: 6274810
    [Abstract] [Full Text] [Related]

  • 6. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 7. Expression of target antigen for Epstein-Barr virus-specific cytotoxic T cells on BJAB cells freshly infected with EBV.
    Sugamura K, Tanaka Y, Hinuma Y.
    Microbiol Immunol; 1982 Jun 01; 26(7):575-83. PubMed ID: 6290853
    [Abstract] [Full Text] [Related]

  • 8. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR.
    Eur J Immunol; 1995 May 01; 25(5):1374-84. PubMed ID: 7774641
    [Abstract] [Full Text] [Related]

  • 9. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
    Torsteinsdottir S, Masucci MG, Brautbar C, Lenoir G, Klein G, Klein E.
    Cell Immunol; 1986 Apr 01; 98(2):453-66. PubMed ID: 3019570
    [Abstract] [Full Text] [Related]

  • 10. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G, Rickinson AB.
    Eur J Immunol; 1987 Jul 01; 17(7):1007-13. PubMed ID: 2440688
    [Abstract] [Full Text] [Related]

  • 11. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.
    Oncol Rep; 2004 Oct 01; 12(4):725-31. PubMed ID: 15375491
    [Abstract] [Full Text] [Related]

  • 12. Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.
    Plotnicky H, Touraine JL.
    Clin Exp Immunol; 1993 Dec 01; 94(3):494-9. PubMed ID: 7504600
    [Abstract] [Full Text] [Related]

  • 13. Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity.
    Torsteinsdottir S, Cuomo L, Klein E, Masucci MG.
    Cell Immunol; 1991 Oct 15; 137(2):501-13. PubMed ID: 1654213
    [Abstract] [Full Text] [Related]

  • 14. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V, DeMars R, Chen BP, Hank JA, Kovats S, Fisch P, Sondel PM.
    J Immunol; 1990 Jul 01; 145(1):36-45. PubMed ID: 1694208
    [Abstract] [Full Text] [Related]

  • 15. Restriction of Epstein-Barr virus-specific cytotoxic T cells by HLA-A, -B, and -C molecules.
    Chen BP, Lam V, Kraus EE, DeMars R, Sondel PM.
    Hum Immunol; 1989 Oct 01; 26(2):137-47. PubMed ID: 2479624
    [Abstract] [Full Text] [Related]

  • 16. Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.
    Kannagi M, Sugamura K, Sato H, Okochi K, Uchino H, Hinuma Y.
    J Immunol; 1983 Jun 01; 130(6):2942-6. PubMed ID: 6189906
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G.
    Proc Natl Acad Sci U S A; 1987 Jul 01; 84(13):4567-71. PubMed ID: 3037521
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.